Related Experiment Videos
Cell cycle control by the thyroid hormone in neuroblastoma cells
Susana Garcia-Silva1, German Perez-Juste, Ana Aranda
1Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain.
Toxicology
|December 31, 2002
Summary
Thyroid hormone (T3) inhibits neuroblastoma cell growth by repressing c-myc and cyclin D1 gene expression. This leads to increased p27(Kip1) levels, blocking cell cycle progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Endocrinology
Background:
- Neuroblastoma is a pediatric cancer.
- Thyroid hormone (T3) plays a role in cell differentiation and proliferation.
- The T3 receptor beta 1 isoform is involved in T3 signaling.
Purpose of the Study:
- To investigate the molecular mechanisms by which T3 affects neuroblastoma cell proliferation and differentiation.
- To elucidate the role of T3 in regulating key cell cycle genes in neuroblastoma cells.
Main Methods:
- Overexpression of T3 receptor beta 1 in N2a-beta cells.
- Analysis of c-myc and cyclin D1 gene transcription.
- Measurement of p27(Kip1) protein levels.
- Assessment of cyclin-CDK2 kinase activity.
- Evaluation of retinoblastoma protein phosphorylation and cell cycle progression.
Main Results:
- T3 treatment blocked proliferation and induced differentiation in N2a-beta cells.
- T3 rapidly repressed c-myc gene expression via a transcription termination element.
- T3 decreased cyclin D1 gene transcription and antagonized Ras-mediated activation.
- T3 significantly increased p27(Kip1) levels, inhibiting cyclin-CDK2 activity.
- T3 treatment resulted in hypophosphorylated retinoblastoma proteins, blocking cell cycle progression at the restriction point.
Conclusions:
- T3 exerts anti-proliferative and differentiation-inducing effects on neuroblastoma cells.
- T3 regulates cell cycle progression by modulating c-myc, cyclin D1, and p27(Kip1) expression.
- The findings provide insights into T3 signaling pathways relevant to neuroblastoma treatment.